Naoero vs Oman: New cases tested for RR-/MDR-TB
Naoero
100.0%
in 2023
Oman
100.0%
in 2024
Naoero rank
1st
Oman rank
1st
New cases tested for RR-/MDR-TB over time
- Naoero
- Oman
How they compare
Naoero currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2009 it was Oman ahead.
Naoero ranks 1st and Oman ranks 1st of 192 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Naoero | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 74.0% | 74.0% | Oman |
| 2010s | 0.0% | 100.0% | 100.0% | Oman |
| 2020s | 75.0% | 89.0% | 14.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Naoero or Oman?
- Naoero, at 100.0% against 100.0% in Oman as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Naoero and Oman?
- 0.0%, with Naoero ahead.
- How many years of comparable data are there for Naoero and Oman?
- 12 years are reported by both, from 2009 to 2023.
- How do Naoero and Oman rank globally for new cases tested for rr-/mdr-tb?
- Naoero ranks 1st and Oman ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.